Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.12% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ISEE
1551
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $5.72M | ﹤0.01% |
1,121,380
-117,600
| -9% | -$490K |
2017 Q1
13 quarters
|
|
|
BPFH
1552
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
| $5.71M | ﹤0.01% |
829,472
-56,828
| -6% | -$398K |
2018 Q3
7 quarters
|
|
1553
Primis Financial Corp
FRST
$381M
| $5.71M | ﹤0.01% |
588,813
-41,700
| -7% | -$401K |
2016 Q2
16 quarters
|
|
1554
John Wiley & Sons Class A
WLY
$2.66B
| $5.71M | ﹤0.01% |
+146,300
| New | +$5.59M |
2020 Q2
0 quarters
|
|
1555
James Hardie Industries
JHX
$14.3B
| $5.71M | ﹤0.01% |
296,527
-103,400
| -26% | -$1.59M |
2014 Q3
23 quarters
|
|
1556
Gartner
IT
$12.4B
| $5.69M | ﹤0.01% |
46,909
+41,265
| +731% | +$4.77M |
2020 Q1
1 quarter
|
|
1557
Radian Group
RDN
$4.47B
| $5.66M | ﹤0.01% |
364,700
+310,000
| +567% | +$4.59M |
2014 Q4
22 quarters
|
|
1558
Safe Bulkers
SB
$986M
| $5.66M | ﹤0.01% |
4,636,186
+32,200
| +0.7% | +$35.3K |
2016 Q2
16 quarters
|
|
1559
DELISTED
Janus Henderson
JHG
| $5.65M | ﹤0.01% |
266,857
+247,057
| +1,248% | +$4.76M |
2018 Q4
6 quarters
|
|
1560
DELISTED
Infinera Corporation Common Stock
INFN
| $5.65M | ﹤0.01% |
954,300
+657,500
| +222% | +$3.6M |
2020 Q1
1 quarter
|
|
1561
Daktronics
DAKT
$896M
| $5.65M | ﹤0.01% |
1,298,300
+45,400
| +4% | +$201K |
2013 Q2
28 quarters
|
|
1562
DELISTED
Retail Value Inc. Common Shares
RVI
| $5.65M | ﹤0.01% |
4,976,972
-755,397
| -13% | -$855K |
2019 Q2
4 quarters
|
|
1563
Otis Worldwide
OTIS
$25.8B
| $5.65M | ﹤0.01% |
+99,300
| New | +$5.14M |
2020 Q2
0 quarters
|
|
1564
VanEck Junior Gold Miners ETF
GDXJ
$8.2B
| $5.64M | ﹤0.01% |
113,800
-21,100
| -16% | -$893K |
2019 Q4
2 quarters
|
|
1565
Valero Energy
VLO
$131B
| $5.63M | ﹤0.01% |
95,688
+76,600
| +401% | +$4.58M |
2019 Q3
3 quarters
|
|
1566
ANI Pharmaceuticals
ANIP
$1.63B
| $5.61M | ﹤0.01% |
173,400
-88,900
| -34% | -$3.19M |
2016 Q2
16 quarters
|
|
1567
Victory Capital Holdings
VCTR
$6.74B
| $5.57M | ﹤0.01% |
324,114
+9,638
| +3% | +$151K |
2018 Q3
7 quarters
|
|
|
CALA
1568
DELISTED
Calithera Biosciences, Inc
CALA
| $5.57M | ﹤0.01% |
52,756
-2,748
| -5% | -$326K |
2017 Q3
11 quarters
|
|
1569
First Community Bankshares
FCBC
$906M
| $5.57M | ﹤0.01% |
248,100
-6,700
| -3% | -$145K |
2013 Q2
28 quarters
|
|
1570
DELISTED
iCAD Inc
ICAD
| $5.57M | ﹤0.01% |
557,370
-102,200
| -15% | -$1.1M |
2013 Q2
28 quarters
|
|
1571
Provident Financial
PROV
$112M
| $5.56M | ﹤0.01% |
414,847
-13,800
| -3% | -$180K |
2013 Q2
28 quarters
|
|
1572
Rogers Corp
ROG
$2.62B
| $5.56M | ﹤0.01% |
44,600
+27,325
| +158% | +$2.92M |
2019 Q3
3 quarters
|
|
1573
Kimball Electronics
KE
$679M
| $5.55M | ﹤0.01% |
410,275
-20,300
| -5% | -$261K |
2014 Q4
22 quarters
|
|
1574
1-800-Flowers.com
FLWS
$166M
| $5.54M | ﹤0.01% |
276,532
+252,692
| +1,060% | +$4.98M |
2019 Q1
5 quarters
|
|
1575
First Northwest Bancorp
FNWB
$93.6M
| $5.54M | ﹤0.01% |
445,705
-15,200
| -3% | -$179K |
2015 Q4
18 quarters
|
|
Similar funds
Renaissance Technologies's Q2 2020 Portfolio in Review
As of Q2 2020, Renaissance Technologies held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Renaissance Technologies withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,365 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Renaissance Technologies opened a new position in Uber worth $187M.
- Renaissance Technologies's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Renaissance Technologies added most to Zoom in Q2 2020, an estimated $806M increase.
- Renaissance Technologies's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Renaissance Technologies fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Renaissance Technologies's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Renaissance Technologies opened 584 new positions and closed 596 in Q2 2020.
- Renaissance Technologies's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.